Upgrade to SI Premium - Free Trial

Royalty Pharma plc (RPRX)

56.13 -0.63 (1.11%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Royalty Pharma (RPRX) PT Raised to $67 at Morgan Stanley October 7, 2026 7:59 AM - StreetInsider Form 4 Royalty Pharma plc For: Oct 05 Filed by: Urist Marshall October 5, 2026 5:13 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Urist Marshall October 5, 2026 4:03 PM - SEC Filing Form 4 Royalty Pharma plc For: Sep 30 Filed by: Bassler Bonnie L September 30, 2026 4:33 PM - SEC Filing Form 4 Royalty Pharma plc For: Sep 28 Filed by: Urist Marshall September 30, 2026 4:32 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Urist Marshall September 28, 2026 4:10 PM - SEC Filing Form 4 Royalty Pharma plc For: Sep 22 Filed by: Hite Christopher September 24, 2026 4:11 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: SCH Investment Partners LLC September 22, 2026 4:51 PM - SEC Filing Royalty Pharma to present at upcoming investor conferences September 9, 2026 4:05 PM - StreetInsider Citi says weakness in shares of this pharma stock is "overdone" September 9, 2026 12:00 PM - StreetInsider Royalty Pharma (RPRX) PT Raised to $68 at TD Cowen September 8, 2026 9:34 AM - StreetInsider Novartis pelacarsen trial fails; Royalty Pharma expects modest return September 4, 2026 7:05 PM - StreetInsider Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen September 4, 2026 7:05 PM - StreetInsider Form 4 Royalty Pharma plc For: Aug 18 Filed by: Hite Christopher August 19, 2026 4:21 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: SCH Investment Partners LLC August 18, 2026 4:45 PM - SEC Filing Form SCHEDULE 13D/A Royalty Pharma plc Filed by: Legorreta Pablo G. August 17, 2026 6:31 PM - SEC Filing Form 4 Royalty Pharma plc For: Aug 13 Filed by: Coyne Terrance P. August 17, 2026 5:01 PM - SEC Filing Form 13F-NT Royalty Pharma plc For: Jun 30 August 14, 2026 11:57 AM - SEC Filing Form 144 Royalty Pharma plc Filed by: Coyne Terrance P. August 13, 2026 4:44 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: DESOUZA ERROL B August 12, 2026 6:33 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: DESOUZA ERROL B August 12, 2026 6:29 PM - SEC Filing Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million August 12, 2026 4:10 PM - StreetInsider Zealand Pharma sells rusfertide royalty rights to Royalty Pharma for $100M August 12, 2026 4:07 PM - StreetInsider Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide August 12, 2026 4:05 PM - StreetInsider Royalty Pharma plc (RPRX) 2K contracts of August 60 calls trade August 10, 2026 2:42 PM - StreetInsider Form 4 Royalty Pharma plc For: Aug 05 Filed by: Legorreta Pablo G. August 7, 2026 5:24 PM - SEC Filing Form 4 Royalty Pharma plc For: Aug 05 Filed by: Coyne Terrance P. August 7, 2026 5:24 PM - SEC Filing Form 4 Royalty Pharma plc For: Aug 05 Filed by: Hite Christopher August 7, 2026 5:12 PM - SEC Filing Form 4 Royalty Pharma plc For: Aug 05 Filed by: Urist Marshall August 7, 2026 5:11 PM - SEC Filing Royalty Pharma (RPRX) PT Raised to $62 at JPMorgan August 7, 2026 9:39 AM - StreetInsider Royalty Pharma (RPRX) PT Raised to $65 at Morgan Stanley August 6, 2026 8:52 AM - StreetInsider Royalty Pharma (RPRX) PT Raised to $63 at BofA Securities August 5, 2026 11:58 AM - StreetInsider Form 10-Q Royalty Pharma plc For: Jun 30 August 5, 2026 9:02 AM - SEC Filing Form 8-K Royalty Pharma plc For: Aug 05 August 5, 2026 7:33 AM - SEC Filing Royalty Pharma reports second quarter 2026 results August 5, 2026 7:00 AM - StreetInsider Royalty Pharma names Greg Raskin to lead academic initiatives August 3, 2026 8:15 AM - StreetInsider Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives August 3, 2026 8:15 AM - StreetInsider Royalty Pharma acquires royalty stake in AstraZeneca's cliramitug July 22, 2026 7:05 AM - StreetInsider Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune July 22, 2026 7:05 AM - StreetInsider Royalty Pharma plc (RPRX) Declares $0.235 Quarterly Dividend; 1.6% Yield July 17, 2026 4:17 PM - StreetInsider Royalty Pharma declares third quarter 2026 dividend July 17, 2026 4:15 PM - StreetInsider Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 July 15, 2026 4:15 PM - StreetInsider Royalty Pharma (RPRX) PT Raised to $65 at TD Cowen July 13, 2026 8:49 AM - StreetInsider Full Article List